GlaxoSmithKline: Diphtheria trials

The registry lists 101 Diphtheria studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 59 have results posted.

Phase 2 15Phase 3 55Phase 4 22No phase 9(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td VaccineCompletedNCT00109330Phase 3